Hepatitis C virus infection and kidney disease: A meta-analysis

Fabrizio Fabrizi, Paul Martin, Vivek Dixit, Piergiorgio Messa

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Background and objectives Hepatitis C virus (HCV) infection and kidney disease are both highly prevalent diseases. The association between HCV and GN has been supported by previous research but little is known about the relationship between HCV and kidney disease. Design, setting, participants, & measurements A systematic review of the published medical literature was conducted to determine if HCV is associated with increased likelihood of kidney disease in the general population. A random-effects model was used to generate a summary estimate of the relative risk for kidney disease, defined as an estimated GFR <60 ml/min per 1.73 m 2 or proteinuria, with HCV across the published studies. Results Nine clinical studies (817,917 unique individuals) were identified. Pooling of study results demonstrated the absence of a relationship between HCV seropositive status and reduced estimated GFR (adjusted relative risk, 1.12; 95% confidence interval, 0.91, 1.38; P=0.28) according to the random-effects model. HCV seropositive serology was an independent and significant risk factor for proteinuria (defined by urine dipstick test or spot urine albumin/creatinine ratio) in the general population, with a summary estimate for adjusted relative risk of 1.47 (95% confidence interval, 1.12, 1.94; P=0.006). Significant heterogeneity was observed between studies (Ri=0.82; P value by Q test, <0.001). Conclusions This meta-analysis shows that HCV is independently associated with proteinuria but not with reduced GFR in the general population. Substantial heterogeneity occurred.

Original languageEnglish
Pages (from-to)549-557
Number of pages9
JournalClinical Journal of the American Society of Nephrology
Volume7
Issue number4
DOIs
StatePublished - Apr 1 2012

Fingerprint

Kidney Diseases
Virus Diseases
Hepacivirus
Meta-Analysis
Proteinuria
Urine
Confidence Intervals
Population
Serology
Albumins
Creatinine
Research

ASJC Scopus subject areas

  • Nephrology
  • Transplantation
  • Epidemiology
  • Critical Care and Intensive Care Medicine

Cite this

Hepatitis C virus infection and kidney disease : A meta-analysis. / Fabrizi, Fabrizio; Martin, Paul; Dixit, Vivek; Messa, Piergiorgio.

In: Clinical Journal of the American Society of Nephrology, Vol. 7, No. 4, 01.04.2012, p. 549-557.

Research output: Contribution to journalArticle

Fabrizi, Fabrizio ; Martin, Paul ; Dixit, Vivek ; Messa, Piergiorgio. / Hepatitis C virus infection and kidney disease : A meta-analysis. In: Clinical Journal of the American Society of Nephrology. 2012 ; Vol. 7, No. 4. pp. 549-557.
@article{63427c58f24e4cb49f660036c355e8c2,
title = "Hepatitis C virus infection and kidney disease: A meta-analysis",
abstract = "Background and objectives Hepatitis C virus (HCV) infection and kidney disease are both highly prevalent diseases. The association between HCV and GN has been supported by previous research but little is known about the relationship between HCV and kidney disease. Design, setting, participants, & measurements A systematic review of the published medical literature was conducted to determine if HCV is associated with increased likelihood of kidney disease in the general population. A random-effects model was used to generate a summary estimate of the relative risk for kidney disease, defined as an estimated GFR <60 ml/min per 1.73 m 2 or proteinuria, with HCV across the published studies. Results Nine clinical studies (817,917 unique individuals) were identified. Pooling of study results demonstrated the absence of a relationship between HCV seropositive status and reduced estimated GFR (adjusted relative risk, 1.12; 95{\%} confidence interval, 0.91, 1.38; P=0.28) according to the random-effects model. HCV seropositive serology was an independent and significant risk factor for proteinuria (defined by urine dipstick test or spot urine albumin/creatinine ratio) in the general population, with a summary estimate for adjusted relative risk of 1.47 (95{\%} confidence interval, 1.12, 1.94; P=0.006). Significant heterogeneity was observed between studies (Ri=0.82; P value by Q test, <0.001). Conclusions This meta-analysis shows that HCV is independently associated with proteinuria but not with reduced GFR in the general population. Substantial heterogeneity occurred.",
author = "Fabrizio Fabrizi and Paul Martin and Vivek Dixit and Piergiorgio Messa",
year = "2012",
month = "4",
day = "1",
doi = "10.2215/CJN.06920711",
language = "English",
volume = "7",
pages = "549--557",
journal = "Clinical journal of the American Society of Nephrology : CJASN",
issn = "1555-9041",
publisher = "American Society of Nephrology",
number = "4",

}

TY - JOUR

T1 - Hepatitis C virus infection and kidney disease

T2 - A meta-analysis

AU - Fabrizi, Fabrizio

AU - Martin, Paul

AU - Dixit, Vivek

AU - Messa, Piergiorgio

PY - 2012/4/1

Y1 - 2012/4/1

N2 - Background and objectives Hepatitis C virus (HCV) infection and kidney disease are both highly prevalent diseases. The association between HCV and GN has been supported by previous research but little is known about the relationship between HCV and kidney disease. Design, setting, participants, & measurements A systematic review of the published medical literature was conducted to determine if HCV is associated with increased likelihood of kidney disease in the general population. A random-effects model was used to generate a summary estimate of the relative risk for kidney disease, defined as an estimated GFR <60 ml/min per 1.73 m 2 or proteinuria, with HCV across the published studies. Results Nine clinical studies (817,917 unique individuals) were identified. Pooling of study results demonstrated the absence of a relationship between HCV seropositive status and reduced estimated GFR (adjusted relative risk, 1.12; 95% confidence interval, 0.91, 1.38; P=0.28) according to the random-effects model. HCV seropositive serology was an independent and significant risk factor for proteinuria (defined by urine dipstick test or spot urine albumin/creatinine ratio) in the general population, with a summary estimate for adjusted relative risk of 1.47 (95% confidence interval, 1.12, 1.94; P=0.006). Significant heterogeneity was observed between studies (Ri=0.82; P value by Q test, <0.001). Conclusions This meta-analysis shows that HCV is independently associated with proteinuria but not with reduced GFR in the general population. Substantial heterogeneity occurred.

AB - Background and objectives Hepatitis C virus (HCV) infection and kidney disease are both highly prevalent diseases. The association between HCV and GN has been supported by previous research but little is known about the relationship between HCV and kidney disease. Design, setting, participants, & measurements A systematic review of the published medical literature was conducted to determine if HCV is associated with increased likelihood of kidney disease in the general population. A random-effects model was used to generate a summary estimate of the relative risk for kidney disease, defined as an estimated GFR <60 ml/min per 1.73 m 2 or proteinuria, with HCV across the published studies. Results Nine clinical studies (817,917 unique individuals) were identified. Pooling of study results demonstrated the absence of a relationship between HCV seropositive status and reduced estimated GFR (adjusted relative risk, 1.12; 95% confidence interval, 0.91, 1.38; P=0.28) according to the random-effects model. HCV seropositive serology was an independent and significant risk factor for proteinuria (defined by urine dipstick test or spot urine albumin/creatinine ratio) in the general population, with a summary estimate for adjusted relative risk of 1.47 (95% confidence interval, 1.12, 1.94; P=0.006). Significant heterogeneity was observed between studies (Ri=0.82; P value by Q test, <0.001). Conclusions This meta-analysis shows that HCV is independently associated with proteinuria but not with reduced GFR in the general population. Substantial heterogeneity occurred.

UR - http://www.scopus.com/inward/record.url?scp=84859522797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859522797&partnerID=8YFLogxK

U2 - 10.2215/CJN.06920711

DO - 10.2215/CJN.06920711

M3 - Article

C2 - 22403269

AN - SCOPUS:84859522797

VL - 7

SP - 549

EP - 557

JO - Clinical journal of the American Society of Nephrology : CJASN

JF - Clinical journal of the American Society of Nephrology : CJASN

SN - 1555-9041

IS - 4

ER -